By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Investment bank Jefferies today restarted coverage of Complete Genomics with a 'Buy' rating and $20 price target.

Jefferies had recently served as joint book-runner for Complete Genomics' secondary offering, which raised net proceeds of $73.8 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.